Sequent Scientific Limited
SEQUENT.NS

$598.01 M
Marketcap
$2.39
Share price
Country
$0.11
Change (1 day)
$2.85
Year High
$1.09
Year Low

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.

marketcap

Sequent Scientific Limited (SEQUENT.NS) - Company Outlook



Company Outlook

Year Receivables Debt Liabilities Assets Current Assets
2023 39.76 M 49.51 M 98.03 M 182.5 M 96.08 M
2022 40.4 M 47.63 M 92.4 M 181.17 M 93.58 M
2021 39.01 M 36.42 M 83.06 M 170.78 M 93.21 M
2020 41.01 M 26.34 M 73.01 M 164.99 M 84.54 M
2019 37.77 M 38.3 M 86.58 M 179.88 M 83.42 M